Case Continued  Patient made aware of low probability of cure (15-40%)  However, she was willing to start treatment  It was accepted that we will assess the continuity of the treatment based on the response rate, i.e., HCV-RNA level, and the severity of adverse effect during the treatment  Fibroscan prior suggested cirrhosis  ALT x 4 ULN  Liver synthetic function normal  Viral load 2.8x10 6 IU/ml
{}